Want to join the conversation?
$XLNX FY15 10-K: Through March 28, 2015, used up $750MM authorized under 2012 Repurchase Program, and $152.6MM of $800MM authorized under 2014 Repurchase Program, leaving $647.4MM available for future repurchases. XLNX’s current policy is to retire all repurchased shares; consequently, no treasury shares were held as of March 28, 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.